Literature DB >> 18523095

Non-responders to bevacizumab (Avastin) therapy of choroidal neovascular lesions.

N Nigam, J Hedaya, W R Freeman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18523095      PMCID： PMC2666011     

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  4 in total

Review 1.  Avastin and new treatments for AMD: where are we?

Authors:  William R Freeman; Iryna Falkenstein
Journal:  Retina       Date:  2006-10       Impact factor: 4.256

2.  Ranibizumab for neovascular age-related macular degeneration.

Authors:  Philip J Rosenfeld; David M Brown; Jeffrey S Heier; David S Boyer; Peter K Kaiser; Carol Y Chung; Robert Y Kim
Journal:  N Engl J Med       Date:  2006-10-05       Impact factor: 91.245

3.  Non-responders to bevacizumab (Avastin) therapy of choroidal neovascular lesions.

Authors:  Anja Lux; Helene Llacer; Florian M A Heussen; Antonia M Joussen
Journal:  Br J Ophthalmol       Date:  2007-05-30       Impact factor: 4.638

4.  Standardized visual acuity results associated with primary versus secondary bevacizumab (avastin) treatment for choroidal neovascularization in age-related macular degeneration.

Authors:  Iryna A Falkenstein; Lingyun Cheng; Victoria L Morrison; Igor Kozak; Ajay M Tammewar; William R Freeman
Journal:  Retina       Date:  2007 Jul-Aug       Impact factor: 4.256
  4 in total
  3 in total

Review 1.  Ocular delivery of macromolecules.

Authors:  Yoo Chun Kim; Bryce Chiang; Xianggen Wu; Mark R Prausnitz
Journal:  J Control Release       Date:  2014-07-03       Impact factor: 9.776

Review 2.  Dyslipidemia in retinal metabolic disorders.

Authors:  Zhongjie Fu; Chuck T Chen; Gael Cagnone; Emilie Heckel; Ye Sun; Bertan Cakir; Yohei Tomita; Shuo Huang; Qian Li; William Britton; Steve S Cho; Timothy S Kern; Ann Hellström; Jean-Sébastien Joyal; Lois Eh Smith
Journal:  EMBO Mol Med       Date:  2019-09-05       Impact factor: 14.260

Review 3.  Targeting Neurovascular Interaction in Retinal Disorders.

Authors:  Zhongjie Fu; Ye Sun; Bertan Cakir; Yohei Tomita; Shuo Huang; Zhongxiao Wang; Chi-Hsiu Liu; Steve S Cho; William Britton; Timothy S Kern; David A Antonetti; Ann Hellström; Lois E H Smith
Journal:  Int J Mol Sci       Date:  2020-02-22       Impact factor: 5.923
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.